One of the major characteristics of anaplastic large cell lymphomas (ALCL) is the expression of the Ki-1/CD30 antigen. While the receptor mediates NF-kB-activation in Hodgkin's lymphomas, some data suggest the CD30-mediated apoptosis of other CD30-expressing cells. We were able to demonstrate that activation of CD30 leads to dierent eects regarding cell proliferation of the ALCL-derived cell lines Karpas 299 and JB6. Western and Northern blotting analysis revealed that CD30-induced growth inhibition of Karpas 299 cells correlated with a strong upregulation of the cell cycle inhibitor p21
Introduction
CD30 is an 120 kDa cell surface receptor, ®rst identi®ed on primary and cultured Reed-Sternberg cells of Hodgkin's disease (HD) (Schwab et al., 1985) . Subsequent studies revealed that CD30 is normally expressed on activated T and B lymphocytes (Ellis et al., 1993) , but also on virus-infected T cells and on a variety of non-Hodgkin's lymphomas (NHL), particularly on anaplastic large-cell lymphoma (ALCL) (Falini et al., 1995) . Cloning and characterization of the cDNA encoding CD30 established the protein as a member of the tumor necrosis factor receptor (TNFR) superfamily (DuÈ rkop et al., 1992) . This family of cytokine receptors is de®ned by sequence homology in the cysteine rich repeats of the extracellular domains (Smith et al., 1994; Baker and Reddy, 1996) . The intracellular parts of the cytokine receptors share no homologue elements, except the so-called death domain, a sequence motif for protein-interaction with death-inducing signal molecules (Ware et al., 1996 , Askenazi et al., 1999 Baker and Reddy, 1998) . As the cytoplasmic domain of TNFRs lacks intrinsic enzymatic activity, the induction of signal transduction pathways occurs by recruitment of signal proteins (Baker and Reddy, 1998; Inoue et al., 2000; Park et al., 2000) like TNFR-associated factors (TRAFs). TRAF proteins share several structural domains and show various anities to dierent motifs within the cytoplasmic domains of TNFRs (Arch et al., 1998) and may contribute to receptor speci®city by forming distinct homo-and heterodimers (Pullen et al., 1998 (Pullen et al., , 1999 .
Interaction of CD30 and the CD30 ligand (CD30L) leads to trimerization and activation of the receptor (DuÈ rkop et al., 1992) . Interestingly, CD30, like other members of the TNFR family, promotes cell survival as well as cell death, probably depending on the CD30-expressing cell type or the cellular context of other costimulatory signals. While CD30 is thought to mediate activation and cell proliferation of HD cells and HDderived cell lines by activation of the nuclear factor kB (NF-kB) (Lee et al., 1996 (Lee et al., , 1997 , preliminary data suggest an antiproliferative eect in ALCL and other CD30-positive cells by CD30-dependent degradation of TRAF2 (Duckett and Thompson, 1997) or induction of cell death (Amakawa et al., 1996; Chiarle et al., 1999) . However, CD30 does not contain a death domain like FAS or TNFR-1, and to date it is not known how CD30 may induce an apoptotic event. A new model for signal transduction of TNFR family members lacking the death domain suggests a TNFRmediated endogenous production of TNF and an autotropic or paratropic activation of TNFR-1 to promote cell death (Grell et al., 1999) . Besides supporting apoptosis, the activated CD30 receptor may alternatively aect cell growth by regulation of cell cycle progression.
We were interested in elucidating, if the CD30-mediated antiproliferative eect on ALCL cells is due to apoptotis or to cell cycle arrest. We could demonstrate that inhibition of cell growth correlated with upregulation of the cyclin-dependent kinase inhibitor (CDKI) p21 CIP1/WAF1 in Karpas 299 cells. Induction of p21 was accompanied by hypophosphorylation of the retinoblastoma protein (Rb) and inactivation of PCNA3, but not by activation of caspase-3 or apoptotic degradation of genomic DNA. We therefore conclude that CD30 is able to induce a cell cycle arrest probably mediated by p21. This is the ®rst proof that CD30 is involved in cell cycle regulation.
Results
Reduced proliferation of CD30-stimulated Karpas 299 cells correlates with upregulation of the cell cycle inhibitor p21
The ALCL cell lines Karpas 299 and JB6, as well as the HD-derived cell line HDLM-2, were cultivated for 72 h with or without CD30 stimulation using immobilized anti-CD30. Cell viability was determined by trypan blue exclusion (Figure 1a ). Cell proliferation of HDLM-2 and of JB6 cells was not signi®cantly aected by CD30 activation, both cell lines showed comparable exponential cell growth (middle and lower panel). In contrast to that, CD30 stimulation resulted in strong inhibition of cell proliferation of Karpas 299 cells (upper panel). The anti-proliferative eect in Karpas 299 cells did not correlate with an increased number of trypan blue-stained cells, indicating no evidence for induced cell death. We were therefore interested in determining if the CD30-mediated inhibition of cell growth was on account of cell cycle restraint. Western blotting analysis demonstrated that growth inhibited cells contained a strongly increased protein level of the cyclin/cyclin-depended kinase inhibitor p21 CIP1/WAF1 (Figure 1b) . In untreated Karpas 299 cells, the p21 protein level was very low or not detectable (upper panel), but was gradually increased when cells were stimulated, with a maximum after 32 h. Expression of p21 was not, or only very slightly, increased in HDLM-2 (lower panel) or JB6 cells (middle panel), respectively, when stimulated with anti-CD30.
Increased protein level of p21 is due to enhanced expression
We have performed Northern blotting experiments to analyse if enhanced expression of p21 is responsible for the abundant p21 protein level in CD30-stimulated Karpas 299 cells. As shown in Figure 2a amounts. Interestingly, RNA expression of p16 and p27 was downregulated upon stimulation with anti-CD30 antibody. In untreated Karpas 299 cells, only a small amount of p21 RNA was detectable, while the RNA level was drastically increased upon stimulation ( Figure 2 ). To prove the equal loading of total RNA in each lane, the membranes were subsequently hybridized with a DNA probe speci®c for the mRNA of L27a, a human ribosomal protein (lowest panel).
Upregulation of p21 is not mediated by p53
To see if expression of p21 in Karpas 299 cells is regulated by the tumor suppressor gene p53, we performed Western blotting experiments and p53 gene mutation analysis. Using anti-p53 antibody, we found that the level of p53 protein was not increased in CD30-stimulated Karpas 299 cells (Figure 3a , left panels). UV radiation of Karpas 299 cells did not induce p53 protein in the time intervals tested, suggesting that the tumor suppressor gene was not activated by irradiation in this cell type (right panels). Equal loading of applied proteins was con®rmed using anti-actin antibody (lower panels). Sequence analysis of exon 5 ± 9 of the p53 gene was performed by PCR reactions of genomic DNA extracted from JB6 and Karpas 299 cells and by subsequent sequence analysis. p53 gene mutation was undetected, but wild-type sequence was detected in the genomic DNA of JB6 cells (data not shown), revealing no possible implication of a mutated p53 protein for resistance of CD30-mediated growth arrest. Instead, we found a nonactivating point mutation in exon 8 within the DNAbinding domain of the p53 gene in Karpas 299 cells. We detected an alteration in codon 273 (CGT?TGT) leading to the exchange of the amino acid arginin to cystein in the p53 protein sequence (Figure 3b ).
Indications of an p21-mediated cell cycle arrest in CD30-stimulated Karpas 299 cells
We were then interested in elucidating molecular events occurring upon the upregulation of p21 in Karpas 299 cells. We have performed Western blotting experiments using untreated and CD30-stimulated Karpas 299 cells (Figure 4a ). While the expression of p16 and p27 was not altered upon CD30 stimulation, p21 protein expression was strongly induced 32 h after stimulation. The retinoblastoma protein (Rb), the main substrate for the cyclin/cyclin-dependent kinase complex, was strongly expressed in untreated and treated cells. In correlation with the upregulation of p21, we detected a considerable shift of the Rb protein by SDS ± PAGE, indicating an apparent decrease of phosphorylation. The expression of the proliferating cell nuclear antigen (PCNA), often reduced in not proliferating cells, was constant despite CD30 stimulation. Subsequently, we have performed immunoprecipitations using anti-p21 antibody ( Figure  4b ). As anticipated, p21 protein could not be immunoprecipitated from unstimulated Karpas 299 cells but from cells stimulated for 32 h (left panel). After For Northern blotting analysis 20 mg of total cellular RNAs were resolved by electrophoresis, transferred on membrane by capillary action and UV cross-linked. DNA probes of p16, p27, p21, and L27a, generated by PCR, were labeled with a-32 P-dCTP and used for hybridization. The panels show the identical membrane after removal of the radioactive probes and subsequent hybridization immunoblotting of the identical membrane using anti-PCNA antibody, co-precipitated PCNA protein was detectable in stimulated Karpas 299 cells (right panel) revealing a strong protein interaction of p21 and PCNA.
Cell cycle analysis with the¯ow cytometer further con®rmed that CD30 stimulation leads to a G0/G1 cell cycle arrest ( Figure 5 ). When untreated Karpas 299 cells (upper panel) or cells treated with unspeci®c antibody (middle panel) were examined, the cells had a typical pro®le of growing cells with a distribution of cells in the G0/G1-, the S-and the G2/M phase. However, Karpas 299 cells, which were stimulated with anti-CD30 antibody (lower panel) were mainly in the G0/G1-phase (72%) and only few cells were still in the end of the last cell cycle in the G2/M-phase.
No induction of CD30-mediated apoptosis in stimulated Karpas 299 cells
To determine if the growth arrest observed in Karpas 299 cells after CD30 stimulation is associated with cell death, we have analysed two hallmarks of apoptotic events. The activation of caspase-3 and the fragmentation of genomic DNA. We could demonstrate that PARP, the 113 kDa poly-(ADP-ribose)-polymerase, which is the main substrate for the activated caspase-3, remains intact in CD30-stimulated Karpas 299 cells (Figure 6a) . In contrast to this, the PARP protein was almost completely cleaved in Karpas 299 cells treated with 3.5 mg/ml epirubicine for 24 h. Immunoblotting revealed that epirubicine-treated cells contained in majority the 89 kDa caspase cleavage product of PARP.
Furthermore, in untreated and CD30 stimulated Karpas 299 cells only intact genomic DNA was detectable, showing no characteristic apoptotic degradation ( Figure 6b ). As a positive control, genomic DNA of epirubicine-treated Karpas 299 cells were extracted and also resolved by electrophoresis. In this control, apoptotic fragmentation was obvious.
Discussion
The activation of members of the tumor necrosis factor receptor (TNFR) family results in the induction of pleiotropic signal cascades by recruiting adapter molecules like the TNFR-associated factors (TRAFs) (Baker and Reddy, 1996) . In this report, we have analysed a new mechanism of CD30-mediated regulation of cell proliferation. CD30, as other members of the TNFR family, is able to promote cell survival as well as cell death (Duckett and Thompson, 1997; Amakawa et al., 1996) . Previous studies have shown that activation of the CD30 receptor results in activation and enhanced proliferation of Hodgkin's lymphoma cells by activation of NF-kB (Lee et al., 1996 (Lee et al., , 1997 , but to induce an antiproliferative eect in anaplastic large cell lymphoma (ALCL) (HuÈ binger et al., 1999; Hsu and Hsu, 2000) and other CD30-positive cell lines, which has been described as induction of cell . Western blotting analysis was performed using whole cell lysate and anti-p53 or anti-actin antibody (b) Genomic DNA was extracted from JB6 and Karpas 299 cells and used for PCR ampli®cation of four genomic regions of p53 (exon 5, exon 6, exon 7, exon 8/9). PCR products were subsequently applied for sequence analysis and compared to the p53 wild-type sequence death (Duckett and Thompson, 1997; Amakawa et al., 1996) (Figure 6 ). Our results con®rmed a growth inhibition for CD30-stimulated Karpas 299 cells. Interestingly, a second ALCL cell line (JB6) did not show a signi®cant inhibition of cell proliferation, when stimulated with immobilized anti-CD30 antibody. As no increased number of cell death was detectable by trypan blue staining of CD30-stimulated Karpas 299 cells, we hypothesized a possible involvement of CD30 in cell cycle regulation. As shown in Figures 1b and 2 , we found a strong upregulation of p21 expression in CD30-stimulated Karpas 299 cells, indicating the induction of a cell cycle arrest, which was con®rmed by¯ow cytometer analysis ( Figure 5 ). Overexpression of this cyclin-dependent kinase inhibitor is sucient to induce cell cycle arrest in a number of cells (Givol et al., 1998; Boulaire et al., 2000; Cariou et al., 2000) . The induction of p21 is often regulated by the tumor suppressor protein p53 (Zuo et al., 1998; Bunz et al., 1998) . Sequence analysis of exon 5 ± 9 of the p53 gene revealed a non-activating point mutation in exon 8 of the p53 gene of Karpas 299 cells. We found no upregulation of the p53 protein in CD30-stimulated or UV-radiated cells using immunoblotting analysis, hence, our results indicate that CD30-mediated activation of p21 expression might occur in an p53-independent manner, as described also for other cellular systems (Lee et al., 1998; de La Fuente et al., 2000) .
Little is known about CD30 induced signaling pathways mediating antiproliferative signals. Duckett and Thompson (1997) supposed a CD30-mediated degradation of TRAF2 to overcome activation of NF-kB and to support cell death, whilst HuÈ binger et al. (1999) noted that the CD30 receptor interacts with the chimeric tyrosine kinase NPM-ALK, expressed in 40 ± 50% of all cases of ALCL due to a t(2;5) chromosomal translocation. Stimulation of CD30 does not enhance tyrosine phosphorylation of cellular proteins, suggesting that CD30 does not use NPM-ALK to transmit signals (HuÈ binger et al., 1999) . Therefore the CD30-induced signaling resulting in enhanced p21 expression remains to be elucidated. However, to substantiate our assumption of an p21-induced cell cycle arrest, we have further analysed Abundant p21 protein inhibits distinct cyclin/cyclindependent kinase complexes leading to dephosphorylation of the retinoblastoma protein (Rb), and as a result to the inhibition of the transcription factor E2F (Brugarolas et al., 1998) . As expected, upregulation of p21 correlated with reduced phosphorylation of Rb in stimulated Karpas 299 cells. In addition, we could show that the proliferating cell nuclear antigen (PCNA), an auxiliary factor for DNA replication and repair, was co-immunoprecipitated with p21 in CD30-stimulated Karpas 299 cells. Association of p21 and PCNA (Zheleva et al., 2000) leads to inhibition of PCNA and can result in G1 and G2 cell cycle arrest (Cayrol et al., 1998) . While the role of p21 in cell cycle arrest is generally accepted, controversial data were obtained considering its role in apoptotic cell death. In this context, p21 was described either to sustain or to induce apoptosis (Ahmad et al., 1998; Tsao et al., 1999) or to possess apoptosis inhibitory activity (Asada et al., 1999; Marches et al., 1999) . As we could neither detect cleavage of the caspase-3 substrate poly (ADPribose) polymerase (PARP) nor apoptotic degradation of genomic DNA, p21 appears not to promote cell death, but exclusively cell cycle arrest in Karpas 299 cells. For clinical treatment of ALCL, it will be interesting to determine the signi®cance of an CD30-mediated cell cycle arrest in this malignancy. While CD30-induced apoptosis might have positive implications for chemotherapy, an CD30-mediated cell cycle arrest could antagonize chemotherapeutical eects and could be responsible for an unfavorable outcome.
Materials and methods

Cells and cell culture
The human ALCL-derived cell lines Karpas 299 and JB6 were maintained in RPMI 1640 (Seromed, Berlin, Germany) supplemented with 10%, the human Hodgkin's lymphoma cell line HDLM-2 supplemented with 20% fetal calf serum (FCS) (Serva, Heidelberg, Germany). Karpas 299 and HDLM-2 cell lines were purchased from DMSZ (Heidelberg, Germany). For CD30 stimulation, culture dishes were coated with 10 mg/ml anti-CD30 antibody (M44 or HeF-1, kindly provided by Immunex (Seattle, USA) or NCI BRB (Rockville, MD, USA) respectively. Cells were then cultivated with or without immobilized M44 up to 72 h. To induce apoptotic cell death, Karpas 299 cells were treated with 3.5 mg/ml epirubicine for 24 ± 48 h. To analyse cell growth kinetics, cells were counted by trypan blue exclusion. For induction of p53, Karpas 299 cells were starved overnight in culture medium supplemented with 0.5% FCS. Before UV exposure, cells were washed twice with 16PBS and covered with 16PBS in Petri dishes. Cells were then irradiated with UV at 40 mJ/cm 2 in the UV-Stratalinker 2400 (Stratagene) and maintained in fresh culture medium.
Immunoprecipitation and Western blotting analysis
Cell lysis was carried out as described previously (HuÈ binger et al., 1999) . For immunoprecipitate, lysates were treated for 3 h with 2 mg anti-p21 antibody (Santa Cruz, Heidelburg, Germany) at 48C, for 1 h with 10 mg of the polyclonal antibody anti-mouse immunoglobulins (DAKO, Glostrup, Denmark), for an additional hour with protein A-Sepharose CL-4B (Pharmacia, Uppsala, Sweden) and subsequently recovered by centrifugation. Cell lysates or extensively washed immunoprecipitates were denatured and resolved by 8, 12 or 15% SDS ± PAGE (HuÈ binger et al., 1999) . After protein transfer to Immobilon-P polyvinylidene di¯uoride (PVDF) membranes (Millipore, Bedford) by semidry or tank blotting, the proteins were visualized by amido black staining. Immunoblotting was performed as described previously (HuÈ binger et al., 1999) using anti-p16, anti-p21, anti-p27, anti-p53, anti-PCNA and anti-actin antibody from Santa Cruz (Heidelberg, Germany) or anti-PARP antibody from Stratagene (Heidelberg, Germany).
Northern blotting analysis
Total cellular RNA was extracted from Karpas 299 cells using the TRIZOL reagent (GIBCO ± BRL, Karlsruhe, Germany) according to the manufacturer's instructions. Northern blotting analysis was carried out using 20 mg of RNA for separation by electrophoresis on 1.2% agarose-formaldehyde gels. RNA was transferred onto positively charged nylon membranes (Boehringer, Mannheim, Germany) by capillary action in 206SSC buer (3 M NaCl, 0.3 M tri-sodium-citratedi-hydrate, pH 7.0) and UV cross-linked. The DNA probes used for detection of p21, p27 and L27a were generated by PCR using Karpas 299 or HDLM2 cDNA prepared by reverse transcription of total RNA and speci®c primers, that were respectively: p16-sense: 5'-CTTCTTGGACACGCTGGT-3'; p16-antisense: 5'-GGATGTCTGAGGGACCTTCC-3'; p21-sense: 5'-ACTTCCTCCTCCCCACTTGT-3'; p21-antisense: 5'-AGGTGAGGGGACTCCAAAGT-3'; p27-sense: 5'-AC-CCCTAGAGGGCAAGTACG-3'; p27-antisense: 5'-AT-CAGTCTTTGGGTCCACCA-3'. The probes were labeled with a-32 P-dCTP using the Rediprime DNA Labelling System (Amersham, Braunschweig, Germany) as described in the manufacturer's protocol. Hybridization was performed in ExpressHyb Hybridization Solution (Clontech, Heidelberg, Germany) at 688C, and the hybridization signals were detected by exposure to X-ray ®lms. For removal of the radioactive probes and subsequent hybridization, the membranes were incubated for 10 min in an 90 ± 1008C warm 0.5% SDS solution and for an additional 5 min in 26SSC solution at room temperature.
Flow cytometer analysis
For the cell cycle analysis, cells were stimulated for 22 ± 30 h as described above or treated with anity puri®ed mouse monoclonal antibody (MAB) 5.4 speci®c for rat CEACAM1 as nonspeci®c control. Flow cytometer analysis was performed as described elsewhere (Singer et al., 2000) . Brie¯y, all cells were resuspended in DNA staining buer containing 16PBS with 0.1% Triton X-100, 100 mg/ml DNAse-free RNAse A and 10 mg/ml propidium iodide and incubated for 10 ± 15 min at room temperature. The stained cells were examined in a FACSCalibur¯ow cytometer (Becton Dickinson) and analysed by CellQuest software.
Analysis of p53 gene mutation
For the detection of p53 gene mutations in exons 5 ± 9, genomic DNA was extracted from Karpas 299 and JB6 cells. Cells were resuspended in 500 ml lysis buer for DNA extraction (0.5% SDS, 100 mM NaCl, 10 mM EDTA and
